{"id":"https://openalex.org/W2783225533","doi":"https://doi.org/10.1136/bmj.k122","title":"Pfizer abandons research into Alzheimer\u2019s and Parkinson\u2019s diseases","display_name":"Pfizer abandons research into Alzheimer\u2019s and Parkinson\u2019s diseases","publication_year":2018,"publication_date":"2018-01-09","ids":{"openalex":"https://openalex.org/W2783225533","doi":"https://doi.org/10.1136/bmj.k122","mag":"2783225533","pmid":"https://pubmed.ncbi.nlm.nih.gov/29317427"},"language":"en","primary_location":{"id":"doi:10.1136/bmj.k122","doi":"https://doi.org/10.1136/bmj.k122","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bmj.k122","pdf_url":null,"source":{"id":"https://openalex.org/S4393917726","display_name":"BMJ","issn_l":"1756-1833","issn":["1756-1833"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ","raw_type":"journal-article"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110124705","display_name":"Nigel Hawkes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nigel Hawkes","raw_affiliation_strings":["London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5110124705"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"360","issue":null,"first_page":"k122","last_page":"k122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.02459999918937683,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12168","display_name":"Health and Medical Research Impacts","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pfizer","display_name":"Pfizer","score":0.9750000238418579},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8930000066757202},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/job-loss","display_name":"job loss","score":0.878000020980835},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.6209999918937683},{"id":"https://openalex.org/keywords/r-d-investment","display_name":"R&D investment","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.45802128314971924},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.45715683698654175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4153987765312195}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1136/bmj.k122","doi":"https://doi.org/10.1136/bmj.k122","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bmj.k122","pdf_url":null,"source":{"id":"https://openalex.org/S4393917726","display_name":"BMJ","issn_l":"1756-1833","issn":["1756-1833"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ","raw_type":"journal-article"},{"id":"pmid:29317427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29317427","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ (Clinical research ed.)","raw_type":"News"},{"id":"pmh:oai:open-archive.highwire.org:bmj:360/jan09_12/k122","doi":null,"is_oa":false,"landing_page_url":"http://www.bmj.com/cgi/content/short/360/jan09_12/k122","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2783447155","https://openalex.org/W2789490228","https://openalex.org/W2785336899","https://openalex.org/W2051475380","https://openalex.org/W3115866691","https://openalex.org/W2317990784","https://openalex.org/W2077044874","https://openalex.org/W4220863314","https://openalex.org/W2047300041","https://openalex.org/W2791451514"],"abstract_inverted_index":{"The":[0,62],"drug":[1],"giant":[2],"Pfizer":[3],"has":[4],"announced":[5],"that":[6],"it":[7,60],"is":[8,58],"pulling":[9],"out":[10],"of":[11,23,74],"early":[12],"stage":[13],"research":[14,76],"into":[15],"Alzheimer\u2019s":[16],"and":[17,54,77],"Parkinson\u2019s":[18],"diseases,":[19],"with":[20],"the":[21,33,70,80],"loss":[22],"300":[24],"jobs.\n\nIts":[25],"money":[26],"can":[27],"be":[28,66],"more":[29],"productively":[30],"invested":[31],"elsewhere,":[32],"company":[34],"said.":[35,61],"\u201cThis":[36],"was":[37],"an":[38],"exercise":[39],"to":[40,46],"reallocate":[41],"spend":[42],"across":[43],"our":[44,52,55],"portfolio,":[45],"focus":[47],"on":[48,88],"those":[49],"areas":[50],"where":[51],"pipeline,":[53],"scientific":[56],"expertise,":[57],"strongest,\u201d":[59],"job":[63],"losses":[64],"will":[65],"at":[67],"sites":[68],"in":[69,85],"US.\n\nMikael":[71],"Dolsten,":[72],"president":[73],"worldwide":[75],"development":[78],"for":[79],"company,":[81],"told":[82],"a":[83],"conference":[84],"San":[86],"Francisco":[87],"8":[89],"January":[90],"\u2026":[91]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-01-26T00:00:00"}